Coming Soon: GI Cancers (ASCO 2024)

Coming Soon: GI Cancers (ASCO 2024)

UPCOMING Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in GI Cancers (ASCO 2024) Sara De Dosso ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND Thibaud Koessler Geneva University Hospitals,...
HER2 in Lung, GYNE & GI Cancers

HER2 in Lung, GYNE & GI Cancers

HER2 in Lung, GYNE & GI Cancers Welcome & introduction by host Ilaria Colombo Clinical implications of HER2 in gastrointestinal cancers Florian Lordick Treatment considerations for HER2-positive lung cancer Maximilian Hochmair Latest treatment updates in...
Biomarkers in GI & Lung

Biomarkers in GI & Lung

Biomarkers in GI & Lung The Significance of Biomarkers in GI Oncology for My Therapy Decision Sara De Dosso Biomarkers in GI Oncology: The Tests We Perform in Gastric and GEJ Today Rupert Langer Current Standards in in Lung Cancer Therapy: Which Biomarkers We...
GI Cancers (ASCO 2023)

GI Cancers (ASCO 2023)

GI Cancers (ASCO 2023) Welcome & introduction by host Thibaud Kössler Latest treatment updates in Upper GI Steve Maron Highlighted data for HCC & Pancreatic Cancer Sara De Dosso Highlights from ASCO for CRC Thibaud Kössler  } 1 h 36 min Get Your CME...
HER2 in Breast, Lung & GI Cancers

HER2 in Breast, Lung & GI Cancers

HER2 in Breast, Lung & GI Cancers Welcome & general introduction into HER2 testing Sabina Berezowska HER2 as a biomarker in breast cancer Zsuzsanna Varga Treatment considerations for HER2-positive GI-cancers Florian Lordick Clinical implications of HER2 in lung...